IDT Australia Overview
- Year Founded
-
1975

- Status
-
Public
- Employees
-
156

- Stock Symbol
-
IDT

- Investments
-
2
- Share Price
-
$0.06
- (As of Thursday Closing)
IDT Australia General Information
Description
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
Contact Information
Website
en.idtaus.com.auCorporate Office
- 45 Wadhurst Drive
- Boronia, Victoria 3155
- Australia
Corporate Office
- 45 Wadhurst Drive
- Boronia, Victoria 3155
- Australia
IDT Australia Stock Performance
As of 17-Apr-2025, IDT Australia’s stock price is $0.06. Its current market cap is $27.4M with 430M shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.06 | $0.06 | $0.05 - $0.10 | $27.4M | 430M | 376K |
IDT Australia Financials Summary
As of 31-Dec-2024, IDT Australia has a trailing 12-month revenue of $11.7M.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
---|---|---|---|---|
EV | 31,419 | 25,132 | 10,660 | 13,335 |
Revenue | 11,658 | 8,668 | 4,662 | 8,772 |
EBITDA | (2,920) | (3,364) | (5,874) | (246) |
Net Income | (3,168) | (3,547) | (5,713) | (841) |
Total Assets | 23,380 | 20,968 | 18,725 | 20,692 |
Total Debt | 2,923 | 2,986 | 490 | 606 |
IDT Australia Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
IDT Australia Signals
IDT Australia Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
IDT Australia Investments & Acquisitions (2)
IDT Australia’s most recent deal was a Corporate Asset Purchase with Sandoz (certain ANDAs) for . The deal was made on 01-Oct-2014.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Sandoz (certain ANDAs) | 01-Oct-2014 | Corporate Asset Purchase | Buildings and Property | ||
CMAX Clinical Research | 27-May-2002 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
IDT Australia ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Pharmaceuticals
Subindustry
Rank
Percentile

IDT Australia FAQs
-
When was IDT Australia founded?
IDT Australia was founded in 1975.
-
Where is IDT Australia headquartered?
IDT Australia is headquartered in Boronia, Australia.
-
What is the size of IDT Australia?
IDT Australia has 156 total employees.
-
What industry is IDT Australia in?
IDT Australia’s primary industry is Pharmaceuticals.
-
Is IDT Australia a private or public company?
IDT Australia is a Public company.
-
What is IDT Australia’s stock symbol?
The ticker symbol for IDT Australia is IDT.
-
What is the current stock price of IDT Australia?
As of 17-Apr-2025 the stock price of IDT Australia is $0.06.
-
What is the current market cap of IDT Australia?
The current market capitalization of IDT Australia is $27.4M.
-
What is IDT Australia’s current revenue?
The trailing twelve month revenue for IDT Australia is $11.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »